# Biocentis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biocentis

- Industry: Biotechnology
- Headquarters: London, UK
- Website: www.biocentis.com/
- Total disclosed funding: $13M
- Latest round: Seed (Nov 5, 2025)
- Investors on record: 5

## About

Biocentis Limited, located in the UK, specializes in innovative solutions for insect control using programmable biology and advanced technologies like genome engineering and artificial intelligence.Founded in 2022 and headquartered in London, UK, Biocentis Limited focuses on developing advanced insect control solutions. The company has engaged in a total of 2 deals, with its most recent funding round being Seed, raising EUR 11.00 mn from investors including Algebris Investments and Grantham Foundation. Biocentis aims to enhance pest management strategies in various sectors.Biocentis specializes in innovative insect control solutions that harness the principles of programmable biology and advanced technologies such as genome engineering and artificial intelligence. Their core offerings focus on disrupting the reproductive cycles of harmful insect populations, thereby reducing reliance on chemical insecticides. This approach aims to address critical issues in public health, agriculture, and biodiversity conservation. The company's products are designed to empower communities to combat disease-carrying vectors, protect crops, and enhance local ecosystems. Biocentis targets markets in Europe and beyond, servicing agricultural producers, public health organizations, and government bodies seeking sustainable pest management strategies.Biocentis generates revenue through a structured model that encompasses both business-to-business and direct partnerships with various stakeholders in agriculture and public health sectors. Transactions involve long-term contracts or subscriptions for their insect control technologies, allowing clients such as farms or vector control agencies to integrate these solutions into their existing operations. The company's flagship offerings provide sustainable pest management, aligning with customer goals of reducing environmental impact while maintaining crop yields and public health standards. Pricing plans are structured to accommodate the diverse needs of their client base, ensuring access to their advanced solutions while fostering ongoing relationships with their partners.In November 2025, Biocentis Limited received USD 6 million in grant funding from the Wellcome Trust, part of a larger USD 19 million Seed and grant funding initiative. The company will utilize this funding to advance programmable insect biology and scale solutions for crop protection and disease control. Biocentis plans to expand its new products that leverage these advancements and enter new markets, specifically targeting regions across Europe.

## Funding rounds

- Seed, Nov 5, 2025, $13M — Algebris Investments, Grantham Foundation, Neurone, Novaterra, Corbites

## Investors

- Algebris Investments (https://capitalatlas.ai/funds/algebris-investments) — Seed
- Grantham Foundation — Seed
- Neurone (https://capitalatlas.ai/funds/neurone) — Seed
- Novaterra — Seed
- Corbites (https://capitalatlas.ai/funds/corbites) — Seed